Thoracic aortic aneurysm medical therapy

Revision as of 16:47, 18 July 2011 by Anjelica Montemayor (talk | contribs) (New page: {{Template:Thoracic aortic aneurysm}} {{CMG}} '''Editor-in-Chief:''' Amjad AlMahameed, MD, MPH, RPVI, FACP. Beth Israel Deaconess Medical Center and Harvard Medical School. Boston, USA ...)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Thoracic aortic aneurysm Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Thoracic Aortic Aneurysm from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

General Approach to Imaging in Thoracic Aortic Aneurysm

Chest X Ray

MRI

CT

Echocardiography

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Endovascular Stent Grafting

Lifestyle Changes

Special Scenarios

Management during Pregnancy

Case Studies

Case #1

Thoracic aortic aneurysm medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Thoracic aortic aneurysm medical therapy

CDC on Thoracic aortic aneurysm medical therapy

Thoracic aortic aneurysm medical therapy in the news

Blogs on Thoracic aortic aneurysm medical therapy

Directions to Hospitals Treating Thoracic aortic aneurysm medical therapy

Risk calculators and risk factors for Thoracic aortic aneurysm medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Editor-in-Chief: Amjad AlMahameed, MD, MPH, RPVI, FACP. Beth Israel Deaconess Medical Center and Harvard Medical School. Boston, USA

Medical Therapy

TAA size is the primary indication for repair. Once a TAA reaches a pre-specified size (>5 cm in the ascending aorta, >6 cm in the descending segment) referral for surgical or endovascular repair sholuld be initiated. Most patients undergo repair once they reach >5.5 for ascending and >6.5 cm for descending TAA, respectively.

In certain populations, such as those with Marfan's syndrome, patients with bicuspid aortic valve (especially when AVR is being considered), personal or family history of prior aortic dissection, or those who have been documented on serial imaging studies to have rapidly expanding aneurysms, clinicians would perform repair sooner (size >4-5 cm for ascending and >5.5-6 cm for descending TAAs).

References

Template:WH Template:WS